Literature DB >> 2060428

Bacteremia in adult diabetic patients.

L Leibovici1, Z Samra, H Konisberger, O Kalter-Leibovici, S D Pitlik, M Drucker.   

Abstract

OBJECTIVE: To compare the microbiology, sources, complications, and outcome of bacteremia in diabetic and nondiabetic patients. RESEARCH DESIGN AND METHODS: A prospective study was conducted of all episodes of bacteremia in hospitalized diabetic and nondiabetic patients. The study consisted of patients greater than or equal to 18 yr of age with bacteremia detected within a 19-mo interval.
RESULTS: We compared 124 episodes of bacteremia in 119 diabetic patients to 508 episodes in 480 nondiabetic patients. Diabetic patients were older than nondiabetic patients (median age 74 vs. 68 yr, P = 0.0001). In patients with an indwelling urinary catheter and bacteremic urinary tract infection, the percentage of Klebsiella in diabetic patients was 60% (6 of 10) and in nondiabetic patients was 17% (4 of 23, P = 0.04). In patients without an obvious source of bacteremia, the percentage of staphylococcal isolates in diabetic patients was 29% (10 of 35) and in nondiabetic patients was 14% (24 of 176, P = 0.04). Staphylococci were a common cause of bacteremic infections of the extremities in diabetic patients (12 of 19, 63%) and nondiabetic patients (20 of 50, 40%). Septic shock was the only complication that was more common in diabetic patients. The mortality in diabetic and nondiabetic patients was 28 and 29%, respectively.
CONCLUSIONS: Our results represent elderly patients with non-insulin-dependent diabetes mellitus. In this group, empirical treatment for suspected bacteremic urinary tract infection in patients with a urinary catheter should include coverage for Klebsiella. Empiric treatment for suspected bacteremia of unknown origin or caused by infection of the extremities should include an antistaphylococcal drug. The prognosis of bacteremia in diabetic and nondiabetic patients was similar.

Entities:  

Mesh:

Year:  1991        PMID: 2060428     DOI: 10.2337/diacare.14.2.89

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis.

Authors:  Z A Kanafani; W M Kourany; V G Fowler; D P Levine; G A Vigliani; M Campion; D E Katz; G R Corey; H W Boucher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12       Impact factor: 3.267

2.  Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts.

Authors:  Vered Daitch; Yulia Akayzen; Yasmin Abu-Ghanem; Noa Eliakim-Raz; Mical Paul; Leonard Leibovici; Dafna Yahav
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-20       Impact factor: 3.267

3.  Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis.

Authors:  L Leibovici; A J Wysenbeek; H Konisberger; Z Samra; S D Pitlik; M Drucker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

4.  Outcome of Community-Acquired Staphylococcus aureus Bacteraemia in Patients with Diabetes: A Historical Population-Based Cohort Study.

Authors:  Jesper Smit; Reimar Wernich Thomsen; Henrik Carl Schønheyder; Henrik Nielsen; Trine Frøslev; Mette Søgaard
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

5.  The double burden of diabetes and global infection in low and middle-income countries.

Authors:  Susanna Dunachie; Parinya Chamnan
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-02-01       Impact factor: 2.184

Review 6.  Human circulating bacteria and dysbiosis in non-infectious diseases.

Authors:  Mohsan Ullah Goraya; Rui Li; Abdul Mannan; Liming Gu; Huixiong Deng; Gefei Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.